Protein structures obtained in part at the ALS helped researchers increase the potency of simplified antibodies (nanobodies) to neutralize SARS-CoV-2. Stable enough to be used in inhalers or nasal sprays, the nanobodies offer a new option for COVID-19 prevention and treatment. https://als.lbl.gov/inhalable-covid-19-protection-via-synthetic-nanobodies/
January 2019 – July 2022
